Genomatica, Inc.
PrivateLast Round
Joint Venture
Jun 16, 2022
Total Funding Raised
$324.23M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Genomatica, Inc. is a biotechnology company that develops commercial biobased processes to produce essential chemicals for sustainable everyday products.
Sector
Energy & Sustainability
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing, Circular Economy
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomatica, Inc. Comparables
Compare Genomatica, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amyris | 80% | |
| Lygos | 75% | |
| Checkerspot | 74% |
Genomatica, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Joint Venture | Jun 16, 2022 | ||||
| Series C | Jul 27, 2021 | ||||
| VC Round | Oct 3, 2018 | ||||
| Series D | Aug 2, 2012 | ||||
| Grant | Aug 1, 2011 | ||||
Series C Extension | Apr 1, 2011 |
Key People
Founding team and executive leadership
Genomatica, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tenere Capital | Series C |
| Bright Capital | Series C Extension |
| Nicholas Investment Partners | Series C |
| Alloy Ventures | Series C, Series B, Series A, Series C Extension, Series D, Series A Extension |
| DFJ Ventures | Series C, Series D |
| Mohr Davidow Ventures | Series C, Series B, Series A, Series C Extension, Series D |
| Irving Investors | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 117% MoM, reaching 6.4K.
- Oct 13, 2025
Partnered with Sojitz Corporation to commercialize plant-based nylon-6.
Genomatica, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genomatica, Inc.'s valuation, stock price, and market status.
Is Genomatica a public or private company?
Genomatica is a private company.
What is the current stock price of Genomatica?
Genomatica is a private company with no public stock price. No recent secondary market data is available.
How much is Genomatica worth (valuation)?
Valuation information for Genomatica is not publicly available.
Can I buy Genomatica stock?
Genomatica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genomatica's last funding round?
Genomatica's most recent funding round was Series C on July 27, 2021.
Who are the main investors in Genomatica?
Key investors in Genomatica include Alloy Ventures, Novo Holdings, VantagePoint Venture Partners, Casdin Capital, TPG Biotech.
Will Genomatica IPO soon?
No public IPO plans have been announced for Genomatica.
How can I track Genomatica secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genomatica's secondary market activity and sign up for updates.